Skip to main content
Top
Published in: Obesity Surgery 12/2018

01-12-2018 | Original Contributions

Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis

Authors: Basile Njei, Thomas R. McCarty, Prabin Sharma, Andrew Lange, Nilofar Najafian, Julius N. Ngu, Valmy E. Ngomba, Justin B. Echouffo-Tcheugui

Published in: Obesity Surgery | Issue 12/2018

Login to get access

Abstract

Background

The association between obesity and rising incidence of hepatocellular carcinoma (HCC) in the USA has been documented; however, the role of bariatric surgery remains less clear.

Aim

To evaluate the cross-sectional association of prior-bariatric surgery and HCC.

Methods

The United States Nationwide Inpatient Sample (NIS) database was queried from 2004 to 2014 for discharges with a diagnosis of morbid obesity. Primary outcomes of interest were HCC and in-hospital mortality rate. Secondary outcomes were length of stay and cost. Baseline characteristics were balanced using propensity score matching (PSM). Using Poisson and logistic regressions, adjusted HCC prevalence ratio (PR) and mortality odds ratio (OR) were derived in patients with prior-bariatric surgery compared to those without bariatric surgery.

Results

Of the 2,881,414 patients included in our study, 267,082 (9.3%) underwent bariatric surgery. From 2004 to 2014, there was a threefold increase in age-adjusted prevalence of HCC from 27 per 100,000 to 72 per 100,000 (PTrend < 0.001). After PSM, 230,956 patients with prior-bariatric surgery were matched with 230,956 patients without bariatric surgery. Prior-bariatric surgery was associated with lower prevalence of HCC (PR 0.11; 95% CI, 0.03–0.48; P < 0.001). In-hospital mortality was also lower for patients with surgery (OR 0.22; 95% CI, 0.20–0.26; P < 0.001). The occurrence of HCC added $18,840 extra cost, increased mean length of stay by 2 (95% CI; 1–3) days, and increased risk of death by 65% (aOR 1.65; 95% CI 1.18–2.29).

Conclusion

In this nationwide study of morbidly obese patients, prior-bariatric surgery was associated with a lower prevalence of HCC and lower in-patient mortality.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60:1767–75.CrossRef El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60:1767–75.CrossRef
3.
go back to reference Njei B, Rotman Y, Ditah I, et al. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61:191–9.CrossRef Njei B, Rotman Y, Ditah I, et al. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61:191–9.CrossRef
4.
go back to reference El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–23.CrossRef El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–23.CrossRef
5.
go back to reference Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:S97–103.CrossRef Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:S97–103.CrossRef
6.
go back to reference Mitchell NS, Catenacci VA, Wyatt HR, et al. Obesity: overview of an epidemic. Psychiatr Clin N Am. 2011;34:717–32.CrossRef Mitchell NS, Catenacci VA, Wyatt HR, et al. Obesity: overview of an epidemic. Psychiatr Clin N Am. 2011;34:717–32.CrossRef
7.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.CrossRef Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.CrossRef
8.
go back to reference Moller H, Mellemgaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344–50.CrossRef Moller H, Mellemgaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344–50.CrossRef
9.
go back to reference Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21.CrossRef Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21.CrossRef
11.
go back to reference Dudekula A, Rachakonda V, Shaik B, et al. Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits. PLoS One. 2014;9:e111808.CrossRef Dudekula A, Rachakonda V, Shaik B, et al. Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits. PLoS One. 2014;9:e111808.CrossRef
13.
go back to reference Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93:1062–7.CrossRef Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93:1062–7.CrossRef
14.
go back to reference Yang B, Yang HP, Ward KK, et al. Bariatric surgery and liver cancer in a consortium of academic medical centers. Obes Surg. 2016;26:696–700.CrossRef Yang B, Yang HP, Ward KK, et al. Bariatric surgery and liver cancer in a consortium of academic medical centers. Obes Surg. 2016;26:696–700.CrossRef
15.
go back to reference Lam PH, Obirieze AC, Ortega G, et al. Characterization of hepatitis B and C among liver transplant recipients with hepatocellular carcinoma: an analysis of the nationwide inpatient sample database. Transplant Proc. 2016;48:123–7.CrossRef Lam PH, Obirieze AC, Ortega G, et al. Characterization of hepatitis B and C among liver transplant recipients with hepatocellular carcinoma: an analysis of the nationwide inpatient sample database. Transplant Proc. 2016;48:123–7.CrossRef
16.
go back to reference McCarty TR, Echouffo-Tcheugui JB, Lange A, et al. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012. Surg Obes Relat Dis. 2018;14:74–80.CrossRef McCarty TR, Echouffo-Tcheugui JB, Lange A, et al. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012. Surg Obes Relat Dis. 2018;14:74–80.CrossRef
18.
go back to reference Abbas A, Medvedev S, Shores N, et al. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci. 2014;59:2813–20.CrossRef Abbas A, Medvedev S, Shores N, et al. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci. 2014;59:2813–20.CrossRef
19.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRef Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRef
20.
go back to reference Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092–7.CrossRef Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092–7.CrossRef
21.
go back to reference Funk MJ, Westreich D, Wiesen C, et al. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173:761–7.CrossRef Funk MJ, Westreich D, Wiesen C, et al. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173:761–7.CrossRef
23.
go back to reference Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103–17.CrossRef Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103–17.CrossRef
24.
go back to reference Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005–8.CrossRef Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005–8.CrossRef
25.
go back to reference Hassan MM, Abdel-Wahab R, Kaseb A, et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology. 2015;149:119–29.CrossRef Hassan MM, Abdel-Wahab R, Kaseb A, et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology. 2015;149:119–29.CrossRef
26.
go back to reference Schutte K, Balbisi F, Malfertheiner P. Prevention of hepatocellular carcinoma. Gastrointest Tumors. 2016;3:37–43.CrossRef Schutte K, Balbisi F, Malfertheiner P. Prevention of hepatocellular carcinoma. Gastrointest Tumors. 2016;3:37–43.CrossRef
27.
go back to reference Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56:704–13.CrossRef Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56:704–13.CrossRef
28.
go back to reference Reeves HL, Zaki MY, Day CP. Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci. 2016;61:1234–45.CrossRef Reeves HL, Zaki MY, Day CP. Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci. 2016;61:1234–45.CrossRef
29.
go back to reference Font-Burgada J, Sun B, Karin M. Obesity and Cancer: the oil that feeds the flame. Cell Metab. 2016;23:48–62.CrossRef Font-Burgada J, Sun B, Karin M. Obesity and Cancer: the oil that feeds the flame. Cell Metab. 2016;23:48–62.CrossRef
30.
go back to reference Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol. 2016;22:394–406.CrossRef Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol. 2016;22:394–406.CrossRef
31.
go back to reference Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013;35:191–202.CrossRef Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013;35:191–202.CrossRef
32.
go back to reference Bougoulia M, Triantos A, Koliakos G. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens). 2006;5:259–69.CrossRef Bougoulia M, Triantos A, Koliakos G. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens). 2006;5:259–69.CrossRef
34.
go back to reference Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRef Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRef
35.
go back to reference Fischer L, Hildebrandt C, Bruckner T, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22:721–31.CrossRef Fischer L, Hildebrandt C, Bruckner T, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22:721–31.CrossRef
36.
go back to reference Khan S, Rock K, Baskara A, et al. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211:1041–6.CrossRef Khan S, Rock K, Baskara A, et al. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211:1041–6.CrossRef
37.
go back to reference O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.CrossRef O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.CrossRef
38.
go back to reference Phillips E, Ponce J, Cunneen SA, et al. Safety and effectiveness of realize adjustable gastric band: 3-year prospective study in the United States. Surg Obes Relat Dis. 2009;5:588–97.CrossRef Phillips E, Ponce J, Cunneen SA, et al. Safety and effectiveness of realize adjustable gastric band: 3-year prospective study in the United States. Surg Obes Relat Dis. 2009;5:588–97.CrossRef
39.
go back to reference Davila JA, El-Serag H. The rising incidence of hepatocellular carcinoma in the United States: an update. Gastroenterology. 2012;142(5):Supp 1:S–914.CrossRef Davila JA, El-Serag H. The rising incidence of hepatocellular carcinoma in the United States: an update. Gastroenterology. 2012;142(5):Supp 1:S–914.CrossRef
40.
go back to reference Saunders D, Seidel D, Allison M, et al. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther. 2010;31:1051–63.PubMed Saunders D, Seidel D, Allison M, et al. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther. 2010;31:1051–63.PubMed
Metadata
Title
Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis
Authors
Basile Njei
Thomas R. McCarty
Prabin Sharma
Andrew Lange
Nilofar Najafian
Julius N. Ngu
Valmy E. Ngomba
Justin B. Echouffo-Tcheugui
Publication date
01-12-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 12/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3431-5

Other articles of this Issue 12/2018

Obesity Surgery 12/2018 Go to the issue